These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2065 related items for PubMed ID: 27943261

  • 21. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.
    Grace AG, Mittal A, Jain S, Tripathy JP, Satyanarayana S, Tharyan P, Kirubakaran R.
    Cochrane Database Syst Rev; 2019 Dec 12; 12(12):CD012918. PubMed ID: 31828771
    [Abstract] [Full Text] [Related]

  • 22. BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial.
    Butler K, Inshaw J, Ford D, Bernays S, Scott K, Kenny J, Klein N, Turkova A, Harper L, Nastouli E, Paparini S, Choudhury R, Rhodes T, Babiker A, Gibb D.
    Health Technol Assess; 2016 Jun 12; 20(49):1-108. PubMed ID: 27377073
    [Abstract] [Full Text] [Related]

  • 23. Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.
    Rutherford GW, Horvath H.
    PLoS One; 2016 Jun 12; 11(10):e0162775. PubMed ID: 27736859
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children.
    Lapphra K, Vanprapar N, Chearskul S, Phongsamart W, Chearskul P, Prasitsuebsai W, Chokephaibulkit K.
    Int J Infect Dis; 2008 Nov 12; 12(6):e33-8. PubMed ID: 18573672
    [Abstract] [Full Text] [Related]

  • 25. Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis.
    Shubber Z, Calmy A, Andrieux-Meyer I, Vitoria M, Renaud-Théry F, Shaffer N, Hargreaves S, Mills EJ, Ford N.
    AIDS; 2013 Jun 01; 27(9):1403-12. PubMed ID: 23343913
    [Abstract] [Full Text] [Related]

  • 26. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW, Harris J, Humphreys E.
    Cochrane Database Syst Rev; 2010 Apr 14; (4):CD008494. PubMed ID: 20393969
    [Abstract] [Full Text] [Related]

  • 27. Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral therapy in a South African multicentre cohort.
    Bock P, Fatti G, Grimwood A.
    Int Health; 2013 Jun 14; 5(2):132-8. PubMed ID: 24030113
    [Abstract] [Full Text] [Related]

  • 28. Long-term efficacy and tolerance of efavirenz- and nevirapine-containing regimens in adult HIV type 1 Senegalese patients.
    de Beaudrap P, Etard JF, Guèye FN, Guèye M, Landman R, Girard PM, Sow PS, Ndoye I, Delaporte E, ANRS 1215/1290 Study Group.
    AIDS Res Hum Retroviruses; 2008 Jun 14; 24(6):753-60. PubMed ID: 18507521
    [Abstract] [Full Text] [Related]

  • 29. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.
    Humphreys EH, Hernandez LB, Rutherford GW.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD006517. PubMed ID: 17943914
    [Abstract] [Full Text] [Related]

  • 30. Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
    Wu PY, Cheng CY, Liu CE, Lee YC, Yang CJ, Tsai MS, Cheng SH, Lin SP, Lin DY, Wang NC, Lee YC, Sun HY, Tang HJ, Hung CC.
    PLoS One; 2017 Oct 17; 12(2):e0171596. PubMed ID: 28222098
    [Abstract] [Full Text] [Related]

  • 31. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA.
    Bannister WP, Ruiz L, Cozzi-Lepri A, Mocroft A, Kirk O, Staszewski S, Loveday C, Karlsson A, Monforte Ad, Clotet B, Lundgren JD, EuroSIDA study group.
    AIDS; 2008 Jan 30; 22(3):367-76. PubMed ID: 18195563
    [Abstract] [Full Text] [Related]

  • 32. Antidepressants for depression in adults with HIV infection.
    Eshun-Wilson I, Siegfried N, Akena DH, Stein DJ, Obuku EA, Joska JA.
    Cochrane Database Syst Rev; 2018 Jan 22; 1(1):CD008525. PubMed ID: 29355886
    [Abstract] [Full Text] [Related]

  • 33. Choice of initial antiretroviral drugs and treatment outcomes among HIV-infected patients in sub-Saharan Africa: systematic review and meta-analysis of observational studies.
    Ayele TA, Worku A, Kebede Y, Alemu K, Kasim A, Shkedy Z.
    Syst Rev; 2017 Aug 25; 6(1):173. PubMed ID: 28841912
    [Abstract] [Full Text] [Related]

  • 34. Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults.
    Onwumeh J, Okwundu CI, Kredo T.
    Cochrane Database Syst Rev; 2017 May 25; 5(5):CD009818. PubMed ID: 28542796
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
    Dahourou DL, Amorissani-Folquet M, Malateste K, Amani-Bosse C, Coulibaly M, Seguin-Devaux C, Toni T, Ouédraogo R, Blanche S, Yonaba C, Eboua F, Lepage P, Avit D, Ouédraogo S, Van de Perre P, N'Gbeche S, Kalmogho A, Salamon R, Meda N, Timité-Konan M, Leroy V, MONOD Study Group.
    BMC Med; 2017 Apr 24; 15(1):85. PubMed ID: 28434406
    [Abstract] [Full Text] [Related]

  • 37. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N, Uthman OA, Rutherford GW.
    Cochrane Database Syst Rev; 2010 Mar 17; 2010(3):CD008272. PubMed ID: 20238364
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana.
    Sarfo FS, Sarfo MA, Kasim A, Phillips R, Booth M, Chadwick D.
    J Antimicrob Chemother; 2014 Jan 17; 69(1):254-61. PubMed ID: 24003181
    [Abstract] [Full Text] [Related]

  • 40. Antihelminthics in helminth-endemic areas: effects on HIV disease progression.
    Means AR, Burns P, Sinclair D, Walson JL.
    Cochrane Database Syst Rev; 2016 Apr 14; 4(4):CD006419. PubMed ID: 27075622
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 104.